Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Dec;64(6):1172-6.
doi: 10.1038/bjc.1991.485.

Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer

K Bertelsen  1
Affiliations
Free PMC article
Clinical Trial

Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer

K Bertelsen. Br J Cancer. 1991 Dec.
Free PMC article

Abstract

Between September 1981 and November 1984 the Danish Ovarian Cancer Group (DACOVA) performed two randomised trials. One for adjuvant therapy in stages Ib, Ic and II and one for chemotherapy treatment in stages III and IV. One hundred and twenty patients fulfilled criteria for the early stage protocol but only 60% was randomised. Three hundred and sixty-one fulfilled criteria for the advanced stages protocol, 73% was randomised. In early stages 11% were excluded because of unavoidable reasons and 29% because of avoidable reasons. In contrast, in advanced stages 21% were excluded because of unavoidable reasons and only 6% because of avoidable reasons. Allocation to the early stage protocol varied with stage, histologic type, residual tumour, and the presence of ascites. These factors had no influence upon allocation to the advanced stages protocol. The experience from this study is: only essential and simple questions should be examined in multicentre trials. Patient accrual and the difference between randomisation groups are usually overestimated, large scale trials are often required to get statistically significant differences, and the participation of departments only randomising a small and selected part of their patients is questionable.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Gynecol Oncol. 1990 Jun;37(3):367-73 - PubMed
    1. Cancer. 1980 Mar 15;45(6):1344-51 - PubMed
    1. Gynecol Oncol. 1987 Oct;28(2):161-9 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1979 Nov-Dec;5(11-12):1933-42 - PubMed
    1. Acta Oncol. 1988;27(6A):627-47 - PubMed

Publication types